INTRODUCTION
In most mammals, bilirubin is produced from biliverdin as the end product of haem catabolism. Unconjugated bilirubin (UCB) is bound to albumin in the systemic circulation. In the adult, UCB is taken up from blood by the liver. In this organ, UCB is biotransformed to more water-soluble glucuronic-acidconjugated derivatives, and is subsequently actively secreted into the bile by an ATP-dependent mechanism mediated by multidrug resistance-associated protein 2 (MRP2) [1] .
During intrauterine life, both the very high foetal production of bilirubin, together with the very low expression of uridine diphosphate glucuronyltransferase 1A1 in the foetal liver [2] , probably contribute to the fact that UCB concentrations are higher in foetal than in maternal serum [3, 4] . Although UCB could play a physiological role in the protection against oxidative stress [5] , this pigment can also cause irreversible damage or even death when it becomes accumulated and reaches the brain at toxic levels [6, 7] , the effects being manifested in the kernicterus syndrome [8] . Owing to the immaturity of foetal hepatobiliary function [9] , elimination across the placenta is the major route for the excretion of the majority of foetal UCB [10] .
Owing to the lipophilicity of UCB and the existence of a bilirubin concentration gradient across the placenta in the foetus-to-mother direction [3, 4] , the mechanism responsible for UCB elimination from the foetal blood has been traditionally Abbreviations used: Bf, concentration of unbound [ 3 H]UCB; C t , threshold cycle; E 2 17βG, 17β-D-glucuronosyl oestradiol; HSA, fatty acid-free human serum albumin; hL, human liver; hPl, human placenta; hTCs, human trophoblast cells; K t , binding affinity constant; OATP, multispecific organic aniontransporting polypeptides; RT, reverse transcription; TE buffer, 1 mM EDTA/10 mM Tris, pH 8.0; UCB, unconjugated bilirubin. 1 To whom correspondence should be addressed (e-mail jjgmarin@usal.es).
accepted as being one of simple diffusion across the placenta [11] . However, using plasma membrane vesicles from human placental trophoblast [12] and the in vivo experimental model of in situ perfused rat placenta at term [13] , functional evidence for an important role of carrier-mediated transport of UCB across the placenta has been found. The first step in the transplacental transfer of foetal UCB is the uptake from the foetal blood by the trophoblast. Results from functional studies [12] have suggested that one or several members of the human organic anion-transporting polypeptide (OATP, SLC21A) family (symbols from the Human Gene Nomenclature Committee Data Base are shown in italics) may be candidate carriers for the transport of UCB across this pole of the trophoblast plasma membrane. This resembles what happens at the basolateral plasma membrane of hepatocytes. It has been suggested that the uptake of UCB by liver cells occurs in part by simple diffusion [14] and in part by high-affinity carrier-mediated processes [15] , which may be accounted for by OATP-C (SLC21A6) [16] . However, this is a matter of controversy, because contradictory results have been obtained by separate groups using different expression systems [16, 17] . The role of OATP-8 (SLC21A8) in UCB uptake by the liver is not clear. The available studies indicate that when expressed in HEK293 cells, this carrier is able to transport at least monoglucuronosyl bilirubin [18] .
The aim of the present work was to gain information on the molecular bases of carrier-mediated transport of foetal UCB by the placenta-maternal liver tandem, by investigating the potential involvement of three members of the SLC21A family of carriers for cholephilic organic anions, i.e, OATP-A (SLC21A3), OATP-C and OATP-8 in the uptake of UCB by the trophoblast from the foetal blood and by the maternal hepatocytes from maternal blood. Although in the present work it has been assumed that OATPs are located at the basal pole of trophocyte and hepatocyte plasma membranes, their existence in the apical domain and in intracellular membranes cannot be ruled out.
MATERIAL AND METHODS

Chemicals
Unlabelled UCB, 17β-D-glucuronosyl oestradiol (E 2 17βG) sodium salt, fatty acid-free human serum albumin (HSA), Percoll and culture media were purchased from Sigma-Aldrich (Madrid, Spain). 17β-D-Glucuronosyl [6,7- 3 H]oestradiol ([ 3 H]E 2 17βG; specific activity: 40.5 Ci/mmol) was from PerkinElmer Life Sciences (Madrid, Spain). [ 3 H]UCB (specific activity: 11 Ci/mol) was produced by biosynthetic labelling from the precursor 3,5-[
3 H]δ-aminolevulinic acid (specific activity: 2 Ci/mmol, PerkinElmer Life Sciences), given intravenously to bile-fistula dogs [19] , with isolation and crystallization of the product as reported previously [20] . To minimize its photodegradation, the dissolution and incubation of UCB were performed using aluminium foil-wrapped glassware in a room under a safe red light. The [ 3 H]UCB was dissolved in warm chloroform (< 55
• C) stabilized with 0.5 % (v/v) ethanol, distributed into vials, dried under a nitrogen stream, and the vials were sealed under an argon atmosphere for storage at −20
• C in the dark. The UCB thus obtained contained less than 0.5 % impurities, as determined by mathematical modelling of serial ultrafiltrations of [ 3 H]UCB in a solution of 10 µM HSA [21] .
Isolation of trophoblast cells from human placenta (hPl)
Samples from human liver (hL) biopsies, from cases of negative diagnoses of liver disease and term placentas from uncomplicated pregnancies, were donated by the Department of Gastroenterology and the Department of Obstetrics and Gynecology respectively, at the University Hospital of Salamanca, Spain, in accordance with the protocols and consent forms approved by the Human Subjects Committee of this hospital.
A combination of previously described methods [22] [23] [24] was used to isolate mononucleated human trophocytes (hTCs). A portion of approx. 60 g of placental tissue was thoroughly washed with 500 ml of culture medium 199. This was minced with scissors and washed three times with 100 ml of sterile ice-cold PBS, each time passing the ground tissue through a sterile stainless steel grid. Tissue was enzymatically disaggregated using enzymes • C for 15 min. Released cells were separated from the residual tissue by filtration through a sieve and centrifugation (300 g for 7 min). Cells were resuspended in 10 ml of Dulbecco's modified Eagle's medium supplemented with 10 % (v/v) foetal calf serum. The disaggregation procedure and cell collection were repeated three more times with the remaining tissue and all cells were pooled together. The hTCs were obtained from the middle band (density ranging from 1.051 to 1.065 g/l) of a discontinuous Percoll gradient from 70 % to 10 % (v/v) centrifuged at 1200 g for 20 min. This step was carried out twice. Cells collected from the second Percoll gradient were washed and resuspended with a small volume of PBS.
Total cell numbers were counted using a haemocytometer. Viability was found to be higher than 97 % according to the Trypan Blue exclusion test. To count cytokeratin-7-positive cells collected at different steps of the purification procedure, after fixation on glass slips, the cells were stained immunohistochemically, using monoclonal mouse anti-human cytokeratin-7 antibody (Novocastra, Atom, Barcelona, Spain) and VECTASTAIN R ABC peroxidase kit (Vector Laboratories, Peterborough, U.K.). To obtain the pictures shown in Figure 1 , fixed cells were first stained immunohistochemically as above, except that the secondary antibody was AlexaFluor R 594 goat anti-mouse (Molecular Probes, Leiden, The Netherlands), and then stained with haematoxylin/eosin (Sigma-Aldrich).
Quantitation of gene expression by real-time reverse transcription (RT)-PCR
Total RNA was isolated from freshly obtained total hPl tissue, hTCs and hL biopsies using RNAeasy spin columns from Qiagen (Izasa, Barcelona, Spain). After being treated with RNase-free DNase I (Roche), RNA was quantified fluorimetrically with the RiboGreen RNA-Quantitation kit (Molecular Probes). DNA was synthesized from 2 µg of total RNA using random nonamers and avian myeloblastosis virus RT (Enhanced Avian RT-PCR kit; Sigma-Genosys, Cambridge, U.K.) according to the instructions supplied by the vendor.
Primer oligonucleotides obtained from Sigma-Genosys (Table 1) were designed with the assistance of Primer Express software (PerkinElmer Applied Biosystems, Madrid, Spain) for DNA fragments in the described sequences, and their specificity was checked using BLAST software. The presence of expression for the selected transporter genes was investigated by the detection and subsequent sequencing of mid-size fragments of specific cDNA amplified by 40 cycles of hot-start PCR, using AmpliTaq Gold Polymerase and the primers shown in Table 1 .
Real-time quantitative PCR was then performed using AmpliTaq Gold polymerase (PerkinElmer Applied Biosystems) in an ABI Prism 5700 Sequence Detection System (PerkinElmer Applied Biosystems). The thermal cycling conditions were as follows: a single cycle at 95
• C for 10 min, followed by 50 cycles at 95
• C for 15 s and at 60
• C for 60 s. Detection of amplification products was carried out using SYBR Green I (Molecular Probes). Non-specific products of PCR, as detected by 2.5 % agarose gel electrophoresis or melting temperature curves (Figure 2 ), were not found in any case. Measurement of target gene expression was carried out using standard curves generated by fitting the log 10 of the amount of DNA template against the threshold cycle (C t ) values. The DNA used to build standard curves was obtained previously by RT-PCR from commercial hL total RNA (Invitrogen, Madrid, Spain), purified by 2.5 % agarose gel electrophoresis, followed by extraction and the amount determined by the PicoGreen test (Molecular Probes). The results of mRNA abundance for each target gene in each sample were normalized on the basis of its 18S rRNA content, which was measured with the TaqMan R Ribosomal RNA Control Reagents kit (PerkinElmer Applied Biosystems).
Uptake studies in Xenopus laevis oocytes
Mature female frogs (Xenopus laevis), purchased from Regine Olig (Hamburg, Germany), were used. Animals received humane care as outlined in the National Institutes for Health guidelines for the care and use of laboratory animals. Experimental protocols were approved by the Ethical Committee for Laboratory Animals of the University of Salamanca. Harvesting and preparation of oocytes were carried out as decribed elsewhere [25] .
Synthesis of mRNA for injection into oocytes was performed using recombinant plasmids containing the open reading frame DNA of human OATP-A, OATP-C or OATP-8, all kindly supplied by Dr. Peter J. Meier (Department of Clinical Pharmacology, Zurich University Hospital, Switzerland). These plasmids were isolated from Escherichia coli using the Qiagen Plasmid Mini Kit (IZASA, Barcelona, Spain) and further linearized with restriction enzymes (Roche). mRNAs were synthesized using the T7 mMessage mMachine kit (Ambion; bioNova Cientifica, Madrid, Spain). X. laevis oocytes were microinjected with TE buffer (1 mM EDTA/10 mM Tris, pH 8.0) either alone, which were used to determine non-specific uptake/binding of the substrates, or containing the following amounts of RNA: 25 ng of total RNA from hL, hPl or hTCs, obtained as described above, or 21 ng of mRNA of each carrier. Oocytes were used 2 days after RNA injection, when, on the basis of preliminary experiments on the time-course of functional expression for these carriers, the uptake rate was highest (results not shown).
Uptake studies were carried out using groups of 12 oocytes per data point. Experiments were repeated using three different frogs. Oocytes were washed with substrate-free uptake medium (100 mM choline chloride, 2 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 and 10 mM Hepes/Tris, pH 7.0) and incubated with 100 µl of uptake medium containing the desired amount of the substrate and inhibitor to be tested at 25
• C for the indicated time. Uptake was stopped by the addition of 4 ml of ice-cold uptake medium. The oocytes were washed three times before being collected and placed, in groups of three to increase the radioactivity signal, in vials for dissolution in 200 µl of 10 % (w/v) SDS. ]UCB concentrations were determined by measuring the radioactivity in a liquid-scintillation counter (LS-6500; Beckman, Madrid, Spain), before more uptake medium was added to reach the final desired concentrations of the compounds and to reduce the proportion of DMSO in the final solution to less than 1 % (v/v). The approximate concentration of unbound [ 3 H]UCB (Bf) was calculated using parameters obtained by other workers [15] . Since it has been emphasized that in order to calculate exactly the value of Bf it is necessary to determine the binding affinity constant (K t ) under the same circumstances as those used in transport studies, we used experimental conditions as close as possible to those used to determine K t [15] . These included pH, temperature and the use of HSA from the same source and at equal concentration.
Statistical methods
Unless otherwise stated, results are expressed as means + − S.E.M. For kinetic analyses, the values were fitted to a Michaelis-Menten
Estimations made by linear and non-linear regression analyses were obtained using the UltraFit-v2.1 software provided by Biosoft (Cambridge, U.K.). To calculate the statistical significance of the differences between groups, the paired t-test or the Bonferroni method for multiplerange testing were used, as appropriate.
RESULTS
Expression of OATP-A, OATP-C and OATP-8 in hTCs
Since previous functional studies [12] had suggested the involvement of members of OATP family of carriers in foetal UCB uptake by the placenta, in the present work further efforts to elucidate the presence of OATPs able to transport UCB in trophoblast cells were undertaken. As a first step in this direction, an enriched fraction of hTCs (as indicated by the immunohistochemically localized presence of the specific marker cytokeratin-7) was obtained by two serial centrifugations in discontinuous Percoll gradients of enzymatically disaggregated placental cells (Figure 1 ). To validate the measurement of RNA abundance by realtime quantitative RT-PCR using SYBR Green I as the detection system, it is necessary to distinguish between desired and undesired amplification products. With this aim, melting curves were acquired for each sample and correlated to the agarose gel electrophoresis results (Figures 2A-2C) . The negative first derivatives of the melting curves showed single large peaks, at 78
• C for OATP-A and OATP-C and 77
• C for OATP-8, suggesting the amplification of a single product in each reaction. This was confirmed by agarose gel electrophoresis, which revealed distinct single bands for the amplified products of the expected size: 101 bp for OATP-A, 154 bp for OATP-C and 111 bp for OATP-8. Melting curves and electrophoresis gels for the negative control obtained in reactions without adding DNA template showed no discernible peaks or bands respectively (Figures 2A-2C ).
Standard curves generated by fitting the C t value versus the log 10 of the amount of DNA template (number of copies) previously obtained as described above and added to the reactions, showed the linearity of the fluorescence signal, at least in the 200 − 2 × 10 6 copy range, for all targets used in this study ( Figure 2D ). Differences in the relative efficiencies of the PCR amplifications, as calculated from the slope of the curves, did not exceed 0.4 units among curves obtained with the SYBR Green I detection system, and 0.5 units with curves for 18S rRNA obtained using the TaqMan R probe ( Figure 2D ). These results indicated that neither non-specific products nor primer-dimers appeared in any case, and that the measurements of the amount of DNA obtained by RT were accurate for all three carriers. Moreover, differences in the efficiency among RT reactions were corrected by expressing the results as the amount of 18S rRNA in each sample.
Although the mRNA of OATP-C was not detected in hTCs by analytical RT-PCR, real-time quantitative RT-PCR using specific shorter target sequences did permit its detection, although to a very limited extent, in both hPl (approx. 14 copies/10 9 copies of 18S rRNA) and in hTCs (approx. 64 copies/10 9 copies of 18S Values are means + − S.E.M. from determinations carried out by real-time quantitative RT-PCR using total RNA obtained from hL, hPl or isolated human trophocytes. At least four different preparations for each tissue were obtained and RT-PCR was performed in triplicate for each sample. Expression levels were normalized on the basis of the content of 18S rRNA measured in the same sample. *P < 0.05 as compared with liver; †P < 0.05, as compared with placenta; ‡P < 0.05 on comparing OATP-A and OATP-C with OATP-8 in trophocytes by the Bonferroni method for multiple-range testing.
rRNA). The abundance of mRNA of OATP-A in hPl was much higher than that of OATP-C but much lower than that of OATP-8. As compared with hPl, the mRNA of these latter two carriers was highly enriched in hTCs (Figure 3 ). In the hL, mRNA of OATP-8 was also the most abundant, whilst that of OATP-C was less than half the amount found for OATP-8. In contrast, the amount of mRNA of OATP-A was approx. 200-fold lower than that of OATP-8. In all three cases, the mRNA was markedly higher in hL than in hTCs (Figure 3 ).
Transport studies
Before studying the ability of OATP-A, OATP-C and OATP-8 mRNAs to induce the uptake of Figure 4B ). Although to a lower extent, RNA from hPl also conferred the ability for [ 3 H]-E 2 17βG uptake. When included in the incubation medium, unlabelled UCB and E 2 17βG were able to significantly cis-inhibit [ 3 H]E 2 17βG uptake by oocytes injected with RNA from hPl, hTCs or hL ( Figure 4B ).
In similar experiments in which OATP-A, OATP-C or OATP-8 expression in oocytes was induced by injection of the corresponding mRNA, a marked ability to carry out [ 3 H]UCB uptake was conferred by OATP-C and, to a lower extent, by OATP-8.
OATP-A induced a very low increase in [
3 H]UCB uptake as compared with that observed in oocytes injected with TE buffer alone ( Figure 5A ). Also in these experiments, the presence of either unlabelled UCB or E 2 17βG was found to reduce carrierinduced enhancement in [ 3 H]UCB uptake ( Figure 5A ). When total RNA from hL, hPl and hTCs was injected in X. laevis oocytes, a marked enhancement in their ability Oocytes (36 per data point counted in groups of three) from three different frogs were incubated with 10 µM of the indicated substrate at 25 • C for 60 min. Self-and cross-inhibition by unlabelled E 2 17βG and UCB respectively, were determined by including 100 µM of one of these compounds in the incubation medium. Values are means + − S.E.M. *P < 0.05 as compared with uptake in the absence of unlabelled compounds; †P < 0.05, on comparing [
3 H]UCB uptake in the absence of inhibitors with uptake by oocytes injected with TE buffer alone, by paired t-test. to take up [ 3 H]UCB was found. The strongest effect was seen in oocytes injected with RNA from hL ( Figure 5B ). Although to a much lower extent, RNA from hPl also conferred the ability to take up [ 3 H]E 2 17βG. This capability was higher for RNA from hTCs, but without reaching the level of RNA from hL. In all three cases, co-incubation of oocytes with [ 3 H]UCB and either unlabelled UCB or E 2 17βG resulted in a significant reduction in [ 3 H]UCB uptake ( Figure 5B ). It must be stated that, in order to maximize the radioactivity taken up by the oocytes, the incubations in experiments shown in Figures 4 and 5 were carried out for 60 min, which, as will be discussed below, were not initial velocity conditions.
Owing to the difficulty in distinguishing between the effects of unlabelled inhibitors on the carrier and on [ 3 H]UCB binding to HSA, self-inhibition was confirmed in studies using a range of 10 min is an appropriate time to obtain a marked uptake signal still within the linear period of the uptake process. Using this time, further incubations with [ 3 H]UCB were carried out in the 0-260 nM range of calculated Bf. The findings suggested the presence of a non-saturable process; probably diffusion plus nonspecific binding, which was measured in oocytes injected with TE buffer alone ( Figure 6B ). Although it is not possible to distinguish the contributions of each of the two components mentioned above, the slope of this curve can be assumed as an estimation of the maximal limit for the value of the diffusion constant (K D ) ( Table 2) .
When [ 3 H]UCB uptake by oocytes injected with RNA was calculated by subtracting the radioactivity retained in oocytes injected only with TE and incubated with the same amount of total radioactivity, clear saturation curves were generated by plotting [ 3 H]UCB uptake by oocytes injected with mRNA of OATP-C, OATP-8 or total RNA of hTCs ( Figure 6B ). Under (Table 2) . Nevertheless, the kinetic constants did not differ significantly when the whole theoretical range of Bf was included in the calculation (results not shown), because saturation of the transport process was almost reached at a Bf value below the solubility limit.
Comparison of the values found for the apparent affinity constant (K m ) indicated that the carrier affinity for [
3 H]UCB and transport efficiency, at least in this model, were higher for OATP-C than for OATP-8. The kinetic parameters for [ 3 H]UCB uptake by oocytes injected with the RNA from hTCs resemble more closely those of oocytes expressing OATP-8 than those of cells expressing OATP-C (Table 2) , which is consistent with the abundance of mRNA of both carriers detected in hTCs by real-time quantitative RT-PCR (Figure 3 ).
DISCUSSION
Although the mechanism for placental transfer of foetal bilirubin has traditionally been accepted as being due to simple diffusion, evidence for the existence of a carrier-mediated transport of UCB across the placenta has been recently obtained in vitro using plasma membrane vesicles from hTCs [12] and cultured human choriocarcinoma BeWo cells [29] , and also in vivo, using in situ perfused rat placenta [13] . The results of the present study contribute to the identification of a role for OATP isoforms in carrier-mediated UCB uptake by both components of the placenta-maternal liver tandem excretory pathway for foetal bilirubin.
The first step in the transfer of UCB across the placenta is its uptake from the foetal blood by the trophoblast. In previous studies using plasma membrane vesicles, we have shown that for other cholephilic organic anions, such as bile acids, this process probably involves an anion-exchanger [30] . Using the same experimental model, we have recently found functional evidence for a role of one or several members of the human OATP family in the transport of UCB across this pole of the trophoblast plasma membrane [12] , which is probably similar to what happens at the basolateral plasma membrane of hepatocytes [15, 16, 18] .
Before discussing results based on kinetic studies, it is necessary to consider that, on one hand, the calculated kinetic parameters are approximate for three reasons: (i) the similarity in functionality of carriers between the in vivo situation and that occurring when these proteins are expressed in X. laevis oocytes is not known; (ii) K t was not determined using strictly the same experimental circumstances as those used in transport studies; and finally (iii) α-fetoprotein, which binds UCB with less affinity than albumin, but which is produced in large quantities by the foetal liver and yolk sac, may play a role in the transport of UCB in the foetal serum affecting uptake of this pigment by the placenta [31] . On the other hand, there is no reason to expect that in the in vivo situation there are either dramatically different values for kinetic parameters or changes in their relative magnitude among the different carriers studied here.
At the placental step of foetal UCB excretion, our results clearly point to two important facts: (i) hTCs contain the machinery required to perform carrier-mediated UCB transport, and (ii) OATP-8 is expressed in the placenta, the abundance of its mRNA being particularly enriched in hTCs. Moreover, although OATP-C seems to be a more efficient carrier in transporting UCB than OATP-8, OATP-C is also expressed at a much weaker level in the placenta than OATP-8, which together with the fact that OATP-A is both sparingly abundant in trophoblast cells and is a poor carrier for UCB, leads to the conclusion that OATP-8 probably plays a major role in the uptake of foetal UCB by the placenta. This hypothesis is consistent with the K m value for UCB uptake found in oocytes injected with RNA from hTCs. This and the K m for OATP-8 were of the same order, but slightly higher than that previously found in experiments using plasma membrane vesicles from the foetal pole of the trophoblast [12] . Small quantitative differences between kinetic parameters found in both studies are probably related to model-associated characteristics, such as contamination of the membrane preparations with membranes of other subcellular origins. Moreover, the contribution of additional unidentified carriers to placental UCB uptake by membrane vesicles absent in the oocyte model cannot be ruled out.
Regarding the uptake of UCB by the adult hL, the following comments on the role of the isoforms of OATPs included in the present study do not rule out the involvement of additional carriers in this process. Although transport of substrates other than UCB by OATP-A was initially found to be sensitive to inhibition by UCB [32] , and we have found that mRNA of this carrier induced a low ability to take up this pigment by X. laevis oocytes, the expected contribution of OATP-A is small, owing to both the low efficiency of this carrier in transporting UCB and the relatively low expression in this organ. Indeed, although OATP-A was initially identified in the liver [32] , further screening of its expression in several tissues suggested that it cannot be considered as an important liver carrier for organic anions [33] . In fact, the expression of this carrier is high in some non-hepatic tissues, particularly in different regions of the human brain [34] .
With regard to the role of OATP-C and OATP-8 in bilirubin uptake by the liver, the results of the present study support previous reports indicating the involvement of both carriers in this process [16, 18] . Although OATP-C has been found to confer the ability to take up UCB to HEK293 transfected cells [16] , other authors have failed to observe enhanced UCB uptake by this carrier using HeLa cells as the expression system [17] . In our study, the injection of OATP-C mRNA into X. laevis oocytes conferred on these cells the ability to carry out high affinity UCB uptake.
Regarding the contribution by OATP-8, this carrier has been previously found to be able to transport monoconjugated bilirubin when expressed in HEK293 [18] . The present study indicates that OATP-8 is also able to transport UCB. If extrapolation of the kinetic parameters found for carriers expressed in oocytes to the in vivo situation is assumed (with caution due to the reason given above), an approximate calculation of the OATP-C/OATP-8 ratio for the efficiency of transport, corrected for the level of expression in hL, results in a value for OATP-C that is approx. 3-fold higher than the contribution of OATP-8 in UCB uptake by the liver. However, it must be borne in mind that at normally low serum concentrations of unbound UCB, the predominant relevance of OATP-C in this function could be increased.
Serum concentrations of unbound UCB are higher during intrauterine life, as suggested by the higher concentration of unbound UCB in umbilical cord serum as compared with normal adult serum [35, 36] , which is in agreement with the diminished bilirubin binding capability of serum collected from premature infants [37] and the higher total bilirubin concentration in foetal serum. This situation is consistent with an important role in placental UCB uptake for the carrier with the highest K m value, i.e., OATP-8. In contrast, in the adult, the presence of both OATP-C and OATP-8 with different affinities for the substrate, can collaborate to extract UCB, their contribution being dependent on the serum concentration of unbound UCB.
In conclusion, our results suggest that OATP-8, but not OATP-C, may play a major role in the carrier-mediated uptake of foetal UCB by the placental trophoblast, whereas both OATP-8 and OATP-C may contribute substantially to UCB uptake by adult hepatocytes, OATP-A playing a minor role in both steps of the placenta-maternal liver tandem excretory pathway for foetal bilirubin.
